Tumor cell-derived microvesicles induced not epithelial-mesenchymal transition but apoptosis in human proximal tubular (HK-2) cells: Implications for renal impairment in multiple myeloma

International Journal of Molecular Sciences

Volumn 18, Issue 3, 2017, Pages

  Zhao, Aiqi ^a   Kong, Fancong ^a,b   Liu, Chun Jie ^c   Yan, Guoxin ^a   Gao, Fei ^a   Guo, Hao ^a   Guo, An Yuan ^c   Chen, Zhichao ^a   Li, Qiubai ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NANCHANG UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Microvesicles; Multiple myeloma; Renal impairment

Indexed keywords

CALCEIN; CASPASE 3; CASPASE 8; CASPASE 9; DCC PROTEIN; LET 7B PROTEIN; MICRORNA; MICRORNA 16; MICRORNA 25; MICRORNA 29; PEPTIDES AND PROTEINS; PROTEIN BCL 2; PTBP2 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ROCK 1 PROTEIN; SYNDECAN 1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; BIOLOGICAL MARKER; CADHERIN; CASPASE;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MULTIPLE MYELOMA; OPTICAL DENSITY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; CANCER STAGING; CELL SURVIVAL; COMPLICATION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENETICS; KIDNEY PROXIMAL TUBULE; METABOLISM; MIDDLE AGED; PATHOLOGY; RENAL INSUFFICIENCY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ULTRASTRUCTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOMARKERS; CADHERINS; CASPASES; CELL SURVIVAL; CELL-DERIVED MICROPARTICLES; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY TUBULES, PROXIMAL; MALE; MICRORNAS; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-BCL-2; RENAL INSUFFICIENCY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SYNDECAN-1; VIMENTIN;

EID: 85014183433     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18030513     Document Type: Article

References (40)

1. Dimopoulos, M.A.; Terpos, E.; Chanan-Khan, A.; Leung, N.; Ludwig, H.; Jagannath, S.; Niesvizky, R.; Giralt, S.; Fermand, J.P.; Blade, J.; et al. Renal impairment in patients with multiple myeloma: A consensus statement on behalf of the international myeloma working group. J. Clin. Oncol. 2010, 28, 4976–4984. [CrossRef] [PubMed]
2. Knudsen, L.M.; Hippe, E.; Hjorth, M.; Holmberg, E.; Westin, J. Renal function in newly diagnosed multiple myeloma—A demographic study of 1353 patients. The nordic myeloma study group. Eur. J. Haematol. 1994, 53, 207–212. [CrossRef] [PubMed]
3. Yadav, P.; Cook, M.; Cockwell, P. Current trends of renal impairment in multiple myeloma. Kidney Dis. 2016, 1, 241–257. [CrossRef]
4. Kyle, R.A.; Gertz, M.A.; Witzig, T.E.; Lust, J.A.; Lacy, M.Q.; Dispenzieri, A.; Fonseca, R.; Rajkumar, S.V.; Offord, J.R.; Larson, D.R.; et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin. Proc. 2003, 78, 21–33. [CrossRef] [PubMed]
5. Nordentoft, M. Prevention of suicide and attempted suicide in denmark. Epidemiological studies of suicide and intervention studies in selected risk groups. Dan. Med. Bull. 2007, 54, 306–369. [PubMed]
6. Eleutherakis-Papaiakovou, V.; Bamias, A.; Gika, D.; Simeonidis, A.; Pouli, A.; Anagnostopoulos, A.; Michali, E.; Economopoulos, T.; Zervas, K.; Dimopoulos, M.A.; et al. Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance. Leuk. Lymphoma 2007, 48, 337–341. [CrossRef] [PubMed]
7. Heher, E.C.; Rennke, H.G.; Laubach, J.P.; Richardson, P.G. Kidney disease and multiple myeloma. Clin. J. Am. Soc. Nephrol. 2013, 8, 2007–2017. [CrossRef] [PubMed]
8. Kastritis, E.; Zervas, K.; Symeonidis, A.; Terpos, E.; Delimbassi, S.; Anagnostopoulos, N.; Michali, E.; Zomas, A.; Katodritou, E.; Gika, D.; et al. Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the international staging system (ISS): An analysis of the greek myeloma study group (GMSG). Leukemia 2009, 23, 1152–1157. [CrossRef] [PubMed]
9. Tkach, M.; Thery, C. Communication by extracellular vesicles: Where we are and where we need to go. Cell 2016, 164, 1226–1232. [CrossRef] [PubMed]
10. Van der Pol, E.; Boing, A.N.; Harrison, P.; Sturk, A.; Nieuwland, R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 2012, 64, 676–705. [CrossRef] [PubMed]
11. Liu, Y.; Zhu, X.J.; Zeng, C.; Wu, P.H.; Wang, H.X.; Chen, Z.C.; Li, Q.B. Microvesicles secreted from human multiple myeloma cells promote angiogenesis. Acta Pharmacol. Sin. 2014, 35, 230–238. [CrossRef] [PubMed]
12. Zhu, X.; You, Y.; Li, Q.; Zeng, C.; Fu, F.; Guo, A.; Zhang, H.; Zou, P.; Zhong, Z.; Wang, H.; et al. Bcr-abl1-positive microvesicles transform normal hematopoietic transplants through genomic instability: Implications for donor cell leukemia. Leukemia 2014, 28, 1666–1675. [CrossRef] [PubMed]
13. Yamada, N.; Tsujimura, N.; Kumazaki, M.; Shinohara, H.; Taniguchi, K.; Nakagawa, Y.; Naoe, T.; Akao, Y. Colorectal cancer cell-derived microvesicles containing microrna-1246 promote angiogenesis by activating smad 1/5/8 signaling elicited by pml down-regulation in endothelial cells. Biochim. Biophys. Acta 2014, 1839, 1256–1272. [CrossRef] [PubMed]
14. Sun, L.; Wang, H.X.; Zhu, X.J.; Wu, P.H.; Chen, W.Q.; Zou, P.; Li, Q.B.; Chen, Z.C. Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro. Acta Pharmacol. Sin. 2014, 35, 381–393. [CrossRef] [PubMed]
15. Li, M.; Hering-Smith, K.S.; Simon, E.E.; Batuman, V. Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol. Dial. Transplant. 2008, 23, 860–870. [CrossRef] [PubMed]
16. Chen, X.; Liang, H.; Zhang, J.; Zen, K.; Zhang, C.Y. Secreted micrornas: A new form of intercellular communication. Trends Cell Biol. 2012, 22, 125–132. [CrossRef] [PubMed]
17. Pavkovic, M.; Vaidya, V.S. MicroRNAs and drug-induced kidney injury. Pharmacol. Ther. 2016, 163, 48–57. [CrossRef] [PubMed]
18. Trionfini, P.; Benigni, A.; Remuzzi, G. Micrornas in kidney physiology and disease. Nat. Rev. Nephrol. 2015, 11, 23–33. [CrossRef] [PubMed]
19. Lee, C.G.; Kim, J.G.; Kim, H.J.; Kwon, H.K.; Cho, I.J.; Choi, D.W.; Lee, W.H.; Kim, W.D.; Hwang, S.J.; Choi, S.; et al. Discovery of an integrative network of micrornas and transcriptomics changes for acute kidney injury. Kidney Int. 2014, 86, 943–953. [CrossRef] [PubMed]
20. Serino, G.; Sallustio, F.; Curci, C.; Cox, S.N.; Pesce, F.; de Palma, G.; Schena, F.P. Role of let-7b in the regulation of n-acetylgalactosaminyltransferase 2 in iga nephropathy. Nephrol. Dial. Transplant. 2015, 30, 1132–1139. [CrossRef] [PubMed]
21. Chen, H.H.; Lan, Y.F.; Li, H.F.; Cheng, C.F.; Lai, P.F.; Li, W.H.; Lin, H. Urinary mir-16 transactivated by C/EBPβ reduces kidney function after ischemia/reperfusion-induced injury. Sci. Rep. 2016, 6, 27945. [CrossRef] [PubMed]
22. Rudnicki, M.; Beckers, A.; Neuwirt, H.; Vandesompele, J. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy. Nephrol. Dial. Transplant. 2015, 30, 35–42. [CrossRef] [PubMed]
23. Krishnan, S.R.; Luk, F.; Brown, R.D.; Suen, H.; Kwan, Y.; Bebawy, M. Isolation of human CD138+ microparticles from the plasma of patients with multiple myeloma. Neoplasia 2016, 18, 25–32. [CrossRef] [PubMed]
24. Nasr, S.H.; Valeri, A.M.; Sethi, S.; Fidler, M.E.; Cornell, L.D.; Gertz, M.A.; Lacy, M.; Dispenzieri, A.; Rajkumar, S.V.; Kyle, R.A.; et al. Clinicopathologic correlations in multiple myeloma: A case series of 190 patients with kidney biopsies. Am. J. Kidney Dis. 2012, 59, 786–794. [CrossRef] [PubMed]
25. Heher, E.C.; Goes, N.B.; Spitzer, T.R.; Raje, N.S.; Humphreys, B.D.; Anderson, K.C.; Richardson, P.G. Kidney disease associated with plasma cell dyscrasias. Blood 2010, 116, 1397–1404. [CrossRef] [PubMed]
26. Collino, F.; Bruno, S.; Incarnato, D.; Dettori, D.; Neri, F.; Provero, P.; Pomatto, M.; Oliviero, S.; Tetta, C.; Quesenberry, P.J.; et al. Aki recovery induced by mesenchymal stromal cell-derived extracellular vesicles carrying microRNAs. J. Am. Soc. Nephrol. 2015, 26, 2349–2360. [CrossRef] [PubMed]
27. Zhou, Y.; Xu, H.; Xu, W.; Wang, B.; Wu, H.; Tao, Y.; Zhang, B.; Wang, M.; Mao, F.; Yan, Y.; et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res. Ther. 2013, 4, 34. [CrossRef] [PubMed]
28. Jia, P.; Teng, J.; Zou, J.; Fang, Y.; Wu, X.; Liang, M.; Ding, X. Xenon protects against septic acute kidney injury via mir-21 target signaling pathway. Crit. Care Med. 2015, 43, e250–e259. [CrossRef] [PubMed]
29. Belkaya, S.; Silge, R.L.; Hoover, A.R.; Medeiros, J.J.; Eitson, J.L.; Becker, A.M.; de la Morena, M.T.; Bassel-Duby, R.S.; van Oers, N.S. Dynamic modulation of thymic microRNAs in response to stress. PLoS ONE 2011, 6, e27580. [CrossRef] [PubMed]
30. Marrone, A.K.; Stolz, D.B.; Bastacky, S.I.; Kostka, D.; Bodnar, A.J.; Ho, J. MicroRNA-17~92 is required for nephrogenesis and renal function. J. Am. Soc. Nephrol. 2014, 25, 1440–1452. [CrossRef] [PubMed]
31. Thornberry, N.A.; Lazebnik, Y. Caspases: Enemies within. Science 1998, 281, 1312–1316. [CrossRef] [PubMed]
32. Mrvar-Brecko, A.; Sustar, V.; Jansa, V.; Stukelj, R.; Jansa, R.; Mujagic, E.; Kruljc, P.; Iglic, A.; Hagerstrand, H.; Kralj-Iglic, V. Isolated microvesicles from peripheral blood and body fluids as observed by scanning electron microscope. Blood Cells Mol. Dis. 2010, 44, 307–312. [CrossRef] [PubMed]
33. Zhang, H.M.; Li, Q.; Zhu, X.; Liu, W.; Hu, H.; Liu, T.; Cheng, F.; You, Y.; Zhong, Z.; Zou, P.; et al. Mir-146b-5p within bcr-abl1-positive microvesicles promotes leukemic transformation of hematopoietic cells. Cancer Res. 2016, 76, 2901–2911. [CrossRef] [PubMed]
34. Li, H.; Durbin, R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics 2009, 25, 1754–1760. [CrossRef] [PubMed]
35. Kozomara, A.; Griffiths-Jones, S. Mirbase: Annotating high confidence micrornas using deep sequencing data. Nucleic Acids Res. 2014, 42, D68–D73. [CrossRef] [PubMed]
36. Wang, W.C.; Lin, F.M.; Chang, W.C.; Lin, K.Y.; Huang, H.D.; Lin, N.S. Mirexpress: Analyzing high-throughput sequencing data for profiling microRNA expression. BMC Bioinform. 2009, 10, 328. [CrossRef] [PubMed]
37. Agarwal, V.; Bell, G.W.; Nam, J.W.; Bartel, D.P. Predicting effective microRNA target sites in mammalian mrnas. eLife 2015, 4, e05005. [CrossRef] [PubMed]
38. Betel, D.; Wilson, M.; Gabow, A.; Marks, D.S.; Sander, C. The microRNA.Org resource: Targets and expression. Nucleic Acids Res. 2008, 36, D149–D153. [CrossRef] [PubMed]
39. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498–2504. [CrossRef] [PubMed]
40. Kong, F.; Zhang, L.; Wang, H.; Yuan, G.; Guo, A.; Li, Q.; Chen, Z. Impact of collection, isolation and storage methodology of circulating microvesicles on flow cytometric analysis. Exp. Ther. Med. 2015, 10, 2093–2101. [CrossRef] [PubMed]